11 results
Warfarin color-coded tablets, initial dosing and INR targets

#pharmacology #overview #review #medications #drugs #cardiology #warfarin #management
dosing and INR targets ... #pharmacology #overview ... #review #medications ... #drugs #cardiology ... #warfarin #management
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
Summary of characteristics ... #Antianginal #Medications ... #Cardiology #Pharmacology ... #Management #Therapy ... #Table #Overview
Summary table of mechanism of action, side effect and contraindications of commonly used drugs for tuberculosis.
Summary table of ... medical diagrams, tables ... #pharmacology #medications ... #table #management ... #overview #tuberculosis
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... dm2 #diabetes #medications ... #overview #management
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
the usual INR target ... #management #algorithm ... pharmacology #treatment #medications ... #table #pharmacotherapy ... #decisionaid #cardiology
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Summary of meta-analysis ... Managing BPD Clinical ... summarised in Tables ... Personality #Disorder #Medications ... Effectiveness #Table
Chronic Lymphocytic Leukemia (CLL) - Summary
Overview: 
 • Most common leukemia in adults
 • Disorder of
Leukemia (CLL) - Summary ... Overview: • Most ... immunophenotype Clinical ... low-risk disease • Indications ... hemeonc #diagnosis #management
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
Aplastic Anemia - Overview ... Aplastic Anemia Clinical ... - Antithyroid medications ... • Allogeneic HSCT ... hematology #diagnosis #management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Cardiomyopathy - Summary ... Clinical • Under-recognized ... Delivery • Stable ... support for patients clinically ... #cardiology #treatment
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... Change in clinical ... Stable patients ... one post op Cardiology ... medical and surgical management